Indeed, constitutive activation of ERK1 and ERK2 signaling is frequently observed in human cancers due to mutations in genes that encode RTKs, RAS, BRAF, CRAF, MEK1, and MEK2 [24, 98]. The gene discussed is MAPK1; the disease is cancer.